Agency Forms Undergoing Paperwork Reduction Act Review, 104160-104162 [2024-30480]
Download as PDF
<![CDATA[
104160
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Comprehensive Evaluation of the
Implementation and Uptake of the CDC
Clinical Practice Guideline for
Prescribing Opioids for Pain—New—
National Center for Injury Prevention
and Control (NCIPC), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
Beginning in the 1990s, opioid
prescribing rates for pain management
steadily increased until 2010, remained
steady until 2012, and have declined
since then. The increase in opioid
prescribing rates corresponded with
increases in opioid-involved overdose
deaths, which initially primarily
involved prescription opioids (natural
and semi-synthetic opioids and
methadone). In response to this
emerging crisis, CDC issued the CDC
Guideline for Prescribing Opioids for
Chronic Pain—United States, 2016
(2016 CDC Guideline). Implementing
the 2016 CDC Guideline was associated
with reductions in opioid prescribing
and increases in use of non-opioid
medications for pain. At the same time,
laws and policies related to prescribing
opioids were instituted that misapplied
or were inconsistent with the 2016 CDC
Guideline, potentially contributing to
patient harm. In 2022, CDC released the
CDC Clinical Practice Guideline for
Prescribing Opioids for Pain—United
States, 2022, (2022 CDC Clinical
Practice Guideline) which provided up
to date evidence regarding pain
management approaches and reemphasizes the need for prescribers to
be focused on patient-centered care to
provide effective pain management.
CDC is comprehensively evaluating the
uptake, implementation, and outcomes
of the 2022 CDC Clinical Practice
Guideline on evidence-based care for
pain management to understand its
impact.
To meet CDC’s goal for a rigorous,
comprehensive evaluation, this
collection is proposing a mixed-method
quasi-experimental approach to evaluate
the 2022 CDC Clinical Practice
Guideline. The evaluation includes
dissemination and impact of the 2022
CDC Clinical Practice Guideline through
population-wide changes in prescribing
practices for opioids and medications
for opioid use disorder. Also, evaluation
of the implementation of the 2022 CDC
Clinical Practice Guideline comes from
perspectives of patients, caregivers,
clinicians; and leaders from health
systems, payers, professional
associations, and medical boards.
CDC will use this information
collection to evaluate the dissemination,
impact, and implementation of the 2022
CDC Clinical Practice Guideline to
ensure that Americans have access to
safer, effective ways of managing their
pain. CDC requests OMB approval for an
estimated 310 annual burden hours.
There are no costs to respondents other
than their time.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
Clinicians .........................................................
Clinician Survey .............................................
Invitation .........................................................
Follow up Emails ............................................
Clinician Interview ..........................................
Dentist Interview .............................................
Health System Leaders Interview ..................
Payer Interview ..............................................
Professional Association Leaders Interview ..
Medical Board Leaders Interview ..................
Patient Focus Groups ....................................
Caregiver Focus Groups ................................
Dentists ...........................................................
Health System Leaders ..................................
Payers .............................................................
Professional Association Leaders ...................
Medical Board Leaders ...................................
Patients ...........................................................
Caregivers .......................................................
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–30482 Filed 12–19–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Type of respondents
Centers for Disease Control and
Prevention
[30Day–25–0234]
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘National
Ambulatory Medical Care Survey
(NAMCS)’’ to the Office of Management
and Budget (OMB) for review and
approval. CDC previously published a
‘‘Proposed Data Collection Submitted
for Public Comment and
Recommendations’’ notice on
September 20, 2024 to obtain comments
from the public and affected agencies.
CDC did not receive comments related
to the previous notice. This notice
serves to allow an additional 30 days for
public and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
200
1000
1000
10
2
3
3
3
3
15
15
Number of
responses per
respondent
1
1
1
1
1
2
2
2
2
3
2
Average
burden
per response
(in hours)
10/60
5/60
5/60
1
1
1
1
1
1
1
1
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
electronic, mechanical, or other
E:\FR\FM\20DEN1.SGM
20DEN1
104161
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
National Ambulatory Medical Care
Survey (NAMCS) (OMB Control No.
0920–0234, Exp. 11/30/2025)—
Revision—National Center for Health
Statistics (NCHS), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
The National Ambulatory Medical
Care Survey (NAMCS) was conducted
intermittently from 1973 through 1985,
and annually since 1989. The survey is
conducted under authority of Section
306 of the Public Health Service Act (42
U.S.C. 242k). NAMCS is part of the
Ambulatory Care Component of the
Ambulatory services are rendered in a
wide variety of settings, including
physician/provider offices and hospital
outpatient and emergency departments.
Since more than 65% of ambulatory
medical care visits occur in physician
offices, NAMCS provides data on the
majority of ambulatory medical care
services. In addition to health care
provided in physician offices and
outpatient and emergency departments,
health centers (HCs) play an important
role in the health care community by
providing care to people who might not
be able to afford it otherwise. HCs are
local, non-profit, community-owned
health care settings, which serve
approximately over 30 million
individuals throughout the United
States.
This Revision seeks approval to
conduct changes to all three
components of NAMCS. We plan to
adjust the HC Component and Provider
Survey Component sample sizes. In
2025 the goal is to sample 10,000
advanced practice providers and up to
151 HCs. In 2026 CDC plans to sample
up to 10,000 physicians and up to 171
HCs. Lastly, if funds allow, in 2027 we
will sample up to 10,000 advanced
practice providers and up to 191 HCs.
For 2025–2027, there will be an
additional 3,000 providers sampled
yearly for the Provider Electronic
Component. Additionally, questions on
the Provider Facility Interview, Health
Center Facility Interview and the
Ambulatory Care Provider Interview
will be modified. CDC requests OMB
approval for an estimated annual 22,107
burden hours. There is no cost to
respondents other than their time.
National Health Care Surveys (NHCS), a
family of provider-based surveys that
capture health care utilization from a
variety of settings, including hospital
inpatient and long-term care facilities.
NHCS surveys of health care providers
include NAMCS, the National
Electronic Health Records Survey
(NEHRS, OMB Control No. 0920–1015),
the National Hospital Care Survey (OMB
Control No. 0920–0212), and the
National Post-acute and Long-term Care
Study (OMB Control No. 0920–0943).
An overarching purpose of NAMCS is
to meet the needs and demands for
statistical information about the
provision of ambulatory medical care
services in the United States. This
fulfills one of NCHS missions; to
monitor the nation’s health. In addition,
NAMCS provides ambulatory medical
care data to study: (1) the performance
of the U.S. health care system; (2) care
for the rapidly aging population; (3)
changes in services such as health
insurance coverage change; (4) the
introduction of new medical
technologies; and (5) the use of
electronic health records (EHRs).
Ongoing societal changes have led to
considerable diversification in the
organization, financing, and
technological delivery of ambulatory
medical care. This diversification is
evidenced by the proliferation of
insurance and benefit alternatives for
individuals, the development of new
forms of physician group practices and
practice arrangements (such as officebased practices owned by hospitals), the
increasing role of advanced practice
providers delivering clinical care, and
growth in the number of alternative sites
of care.
ESTIMATED ANNUALIZED BURDEN HOURS
Form name
HC’s Staff .........................................
HC Facility Interview Questionnaire (Survey year:
2024).
Prepare and transmit EHR for Visit Data (quarterly)
(Survey year: 2024).
Set-up Fee Questionnaire (Survey year: 2024) ...........
ACPI (Survey year: 2026) .............................................
Contact Tracing (Survey year: 2026) ...........................
ACPI (Survey year: 2025 & 2027) ................................
Contact Tracing (Survey year: 2025 & 2027) ...............
PFI (Survey year: 2025–2027) .....................................
Prepare and transmit Electronic Visit Data (quarterly)
(Survey year: 2025–2027).
HC Facility Interview Questionnaire (Survey year:
2025–2027).
Prepare and transmit EHR for Visit Data (quarterly)
(Survey year: 2025–2027).
Set-up Fee Questionnaire (Survey year: 2025–2027)
Provider or Staff ...............................
Advanced Practice Provider or Staff
ddrumheller on DSK120RN23PROD with NOTICES1
Number of
respondents
Type of respondents
Ambulatory Care Provider’s or
Group’s or Conglomerate’s Staff.
HC’s Staff .........................................
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
Avg. burden
per response
(in hrs.)
84
1
45/60
50
4
60/60
17
3,333
3,333
6,667
6,667
3000
3000
1
1
1
1
1
1
4
15/60
30/60
10/60
30/60
10/60
45/60
60/60
221
1
45/60
188
4
60/60
17
1
15/60
E:\FR\FM\20DEN1.SGM
20DEN1
104162
Federal Register / Vol. 89, No. 245 / Friday, December 20, 2024 / Notices
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Public Health Ethics and
Regulations, Office of Science, Centers for
Disease Control and Prevention.
[FR Doc. 2024–30480 Filed 12–19–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Safety and Occupational Health Study
Section; Notice of Solicitation of
Nominations for Appointment;
Correction
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice; correction.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), within the
Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Safety and
Occupational Health Study Section
(SOHSS). SOHSS consists of 20 experts
in fields associated with occupational
medicine and nursing, industrial
hygiene, occupational safety and
engineering, toxicology, chemistry,
safety and health education,
ergonomics, epidemiology, economic
science, psychology, pulmonary
pathology/physiology, and social
science.
DATES: Nominations for membership on
SOHSS must be received no later than
January 31, 2025. Packages received
after this time will not be considered for
the current membership cycle.
ADDRESSES: All nominations should be
mailed to Dr. Michael Goldcamp, 1095
Willowdale Road, Morgantown, West
Virginia 26505 or emailed to
MGoldcamp@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Michael Goldcamp, Ph.D., Scientific
Review Officer, Office of Extramural
Programs, National Institute for
Occupational Safety and Health, Centers
for Disease Control and Prevention,
1095 Willowdale Road, Morgantown,
West Virginia 26505. Telephone: (304)
285–5951; email: MGoldcamp@cdc.gov.
SUPPLEMENTARY INFORMATION:
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
Correction
Notice is hereby given of a correction
in the SUPPLEMENTARY INFORMATION
section of the original solicitation of
nominations notice, which was
VerDate Sep<11>2014
20:12 Dec 19, 2024
Jkt 265001
published in the Federal Register on
December 2, 2024, 89 FR 95214.
The notice is being amended to
remove the sentence concerning Special
Government Employees, since members
of the Safety and Occupational Health
Study Section serve as Peer Review
Consultants. The SUPPLEMENTARY
INFORMATION section should read as
follows:
SUPPLEMENTARY INFORMATION:
Nominations are sought for individuals
who have the expertise and
qualifications necessary to contribute to
the accomplishment of the objectives of
the Safety and Occupational Health
Study Section (SOHSS). Nominees will
be selected based on expertise in the
fields of occupational medicine and
nursing, industrial hygiene,
occupational safety and engineering,
toxicology, chemistry, safety and health
education, ergonomics, epidemiology,
economic science, psychology,
pulmonary pathology/physiology, and
social science. Members may be invited
to serve up to four-year terms. Selection
of members is based on candidates’
qualifications to contribute to the
accomplishment of SOHSS objectives
(https://www.cdc.gov/faca/committees/
sohss.html).
Department of Health and Human
Services (HHS) policy stipulates that
committee membership be balanced in
terms of points of view represented and
the committee’s function. Appointments
shall be made without discrimination
on the basis of age, race, ethnicity,
gender, sexual orientation, gender
identity, HIV status, disability, and
cultural, religious, or socioeconomic
status. Nominees must be U.S. citizens
and cannot be full-time employees of
the U.S. Government. Current
participation on Federal workgroups or
prior experience serving on a Federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. The Centers
for Disease Control and Prevention
(CDC) reviews potential candidates for
SOHSS membership each year and
provides a slate of nominees for
consideration to the Secretary of HHS
for final selection. HHS notifies selected
candidates of their appointment near
the start of the term in October 2025, or
as soon as the HHS selection process is
completed. Note that the need for
different expertise varies from year to
year and a candidate who is not selected
in one year may be reconsidered in a
subsequent year.
Candidates should submit the
following items:
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
D Current curriculum vitae, including
complete contact information
(telephone numbers, mailing address,
email address).
D At least one letter of
recommendation from person(s) not
employed by HHS. Candidates may
submit letter(s) from current HHS
employees if they wish, but at least one
letter must be submitted by a person not
employed by an HHS agency (e.g., CDC,
National Institutes of Health, Food and
Drug Administration).
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2024–30410 Filed 12–19–24; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Award of a Sole Source
Cooperative Agreement to Fund
Secretaria Ejecutiva del Consejo de
Ministros de Salud de Centroamerica y
Republica Dominicana (SE–COMISCA)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), located
within the Department of Health and
Human Services (HHS), announces the
award of approximately $5,000,000,
with an expected total funding of
approximately $25,000,000 over a 5-year
period, to SE–COMISCA. The award
will build upon previous efforts by the
CDC in collaboration with Ministries of
Health of Central America and the
Dominican Republic (SE–COMISCA).
DATES: The period for this award will be
September 30, 2025 through September
29, 2030.
SUMMARY:
E:\FR\FM\20DEN1.SGM
20DEN1
]]>Agencies
[Federal Register Volume 89, Number 245 (Friday, December 20, 2024)]
[Notices]
[Pages 104160-104162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-30480]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30Day-25-0234]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled ``National Ambulatory Medical Care Survey
(NAMCS)'' to the Office of Management and Budget (OMB) for review and
approval. CDC previously published a ``Proposed Data Collection
Submitted for Public Comment and Recommendations'' notice on September
20, 2024 to obtain comments from the public and affected agencies. CDC
did not receive comments related to the previous notice. This notice
serves to allow an additional 30 days for public and affected agency
comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other
[[Page 104161]]
technological collection techniques or other forms of information
technology, e.g., permitting electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
National Ambulatory Medical Care Survey (NAMCS) (OMB Control No.
0920-0234, Exp. 11/30/2025)--Revision--National Center for Health
Statistics (NCHS), Centers for Disease Control and Prevention (CDC).
Background and Brief Description
The National Ambulatory Medical Care Survey (NAMCS) was conducted
intermittently from 1973 through 1985, and annually since 1989. The
survey is conducted under authority of Section 306 of the Public Health
Service Act (42 U.S.C. 242k). NAMCS is part of the Ambulatory Care
Component of the National Health Care Surveys (NHCS), a family of
provider-based surveys that capture health care utilization from a
variety of settings, including hospital inpatient and long-term care
facilities. NHCS surveys of health care providers include NAMCS, the
National Electronic Health Records Survey (NEHRS, OMB Control No. 0920-
1015), the National Hospital Care Survey (OMB Control No. 0920-0212),
and the National Post-acute and Long-term Care Study (OMB Control No.
0920-0943).
An overarching purpose of NAMCS is to meet the needs and demands
for statistical information about the provision of ambulatory medical
care services in the United States. This fulfills one of NCHS missions;
to monitor the nation's health. In addition, NAMCS provides ambulatory
medical care data to study: (1) the performance of the U.S. health care
system; (2) care for the rapidly aging population; (3) changes in
services such as health insurance coverage change; (4) the introduction
of new medical technologies; and (5) the use of electronic health
records (EHRs). Ongoing societal changes have led to considerable
diversification in the organization, financing, and technological
delivery of ambulatory medical care. This diversification is evidenced
by the proliferation of insurance and benefit alternatives for
individuals, the development of new forms of physician group practices
and practice arrangements (such as office-based practices owned by
hospitals), the increasing role of advanced practice providers
delivering clinical care, and growth in the number of alternative sites
of care.
Ambulatory services are rendered in a wide variety of settings,
including physician/provider offices and hospital outpatient and
emergency departments. Since more than 65% of ambulatory medical care
visits occur in physician offices, NAMCS provides data on the majority
of ambulatory medical care services. In addition to health care
provided in physician offices and outpatient and emergency departments,
health centers (HCs) play an important role in the health care
community by providing care to people who might not be able to afford
it otherwise. HCs are local, non-profit, community-owned health care
settings, which serve approximately over 30 million individuals
throughout the United States.
This Revision seeks approval to conduct changes to all three
components of NAMCS. We plan to adjust the HC Component and Provider
Survey Component sample sizes. In 2025 the goal is to sample 10,000
advanced practice providers and up to 151 HCs. In 2026 CDC plans to
sample up to 10,000 physicians and up to 171 HCs. Lastly, if funds
allow, in 2027 we will sample up to 10,000 advanced practice providers
and up to 191 HCs. For 2025-2027, there will be an additional 3,000
providers sampled yearly for the Provider Electronic Component.
Additionally, questions on the Provider Facility Interview, Health
Center Facility Interview and the Ambulatory Care Provider Interview
will be modified. CDC requests OMB approval for an estimated annual
22,107 burden hours. There is no cost to respondents other than their
time.
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Avg. burden
Type of respondents Form name Number of responses per per response
respondents respondent (in hrs.)
----------------------------------------------------------------------------------------------------------------
HC's Staff............................ HC Facility Interview 84 1 45/60
Questionnaire (Survey
year: 2024).
Prepare and transmit EHR 50 4 60/60
for Visit Data
(quarterly) (Survey
year: 2024).
Set-up Fee Questionnaire 17 1 15/60
(Survey year: 2024).
Provider or Staff..................... ACPI (Survey year: 2026). 3,333 1 30/60
Contact Tracing (Survey 3,333 1 10/60
year: 2026).
Advanced Practice Provider or Staff... ACPI (Survey year: 2025 & 6,667 1 30/60
2027).
Contact Tracing (Survey 6,667 1 10/60
year: 2025 & 2027).
Ambulatory Care Provider's or Group's PFI (Survey year: 2025- 3000 1 45/60
or Conglomerate's Staff. 2027). 3000 4 60/60
Prepare and transmit
Electronic Visit Data
(quarterly) (Survey
year: 2025-2027).
HC's Staff............................ HC Facility Interview 221 1 45/60
Questionnaire (Survey
year: 2025-2027).
Prepare and transmit EHR 188 4 60/60
for Visit Data
(quarterly) (Survey
year: 2025-2027).
Set-up Fee Questionnaire 17 1 15/60
(Survey year: 2025-2027).
----------------------------------------------------------------------------------------------------------------
[[Page 104162]]
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health
Ethics and Regulations, Office of Science, Centers for Disease Control
and Prevention.
[FR Doc. 2024-30480 Filed 12-19-24; 8:45 am]
BILLING CODE 4163-18-P
